Education: Sharon Longhurst holds a PhD in Virology from the University of Warwick and BScin Biochemistry from the University of Surrey.
Experience: Sharon Longhurst (born 1969) has more than 20 years' experience in CMC development of biological medicinal products, specializing in Advanced Therapy Medicinal Products (ATMP). Her previous positions include VP of Development at Gadeta BV, Head of CMC at Immunium AB (now Mendus) and Akari Therapeutics. She has also worked as a Senior Pharmaceutical Asessor at the MHRA (UK competent authority). Current assignments include Director at Advanced Biologics Consulting Ltd where she provides CMC consulting services to biotech companies.
Independency: Sharon Longhurst is independent in relation to the senior executives of the company and major shareholders.
Shares: 0
